West Pharmaceutical Services

Profile narrative

West Pharmaceutical Services, operating under the alias West Pharmaceutical Services, is a United States–headquartered organisation whose operations intersect with the pharmaceutical sector, specifically in packaging and drug delivery supply chain functions. While the available source material does not detail the firm's full product catalogue, service lines, or specific market segments, its position within the pharmaceutical packaging and drug delivery supply chain is confirmed through incident reporting that references disruptions to these functions. The organisation serves a global footprint, as evidenced by descriptions of the incident's impact on "global business operations" across multiple geographies.

The scale and reach of West Pharmaceutical Services extend across international operations, with the organisation maintaining infrastructure and processes spanning shipping, receiving, and manufacturing activities at multiple sites. Following the disruption, core enterprise systems were restored and critical processes restarted at some locations, while restoration efforts at remaining sites were reported as ongoing. The firm has engaged external cybersecurity expertise, specifically Palo Alto Networks' Unit 42, for threat intelligence, incident response, and investigation support, and has notified law enforcement authorities. Beyond these operational specifics, detailed quantitative metrics regarding the organisation's size, revenue, employee count, or market capitalisation are not provided in the available material.

West Pharmaceutical Services operates within a highly regulated industry context, handling pharmaceutical packaging and drug delivery components that are subject to stringent regulatory oversight governing the pharmaceutical supply chain. The organisation demonstrates a capacity for incident response coordination, having engaged specialised third-party cybersecurity responders and law enforcement in parallel. Its sector positioning places it within the broader pharmaceutical services ecosystem, where supply chain integrity and continuity are critical attributes. The firm is currently investigating the extent of data exfiltrated during the incident and has taken mitigation steps to reduce the risk of data dissemination, though it has not determined whether the incident will materially impact its financial condition or operational results.

Regarding structural and ownership details, the available source material does not specify parent-subsidiary relationships, ownership structure, or corporate hierarchy. Whether West Pharmaceutical Services operates as a standalone public entity, a division of a larger conglomerate, or under alternative corporate forms is not stated in the provided context. The headquarters location in the United States of America is confirmed, but further corporate structural information cannot be determined from the available material.

Incidents

1 incident linked to this organisation.